BioCryst Reports Second Quarter 2017 Financial Results

Go back to BioCryst Reports Second Quarter 2017 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 9.86 -0.73 (6.89%)
Previous Close $10.59    52 Week High $10.98 
Open $10.59    52 Week Low $1.63 
Day High $10.63    P/E N/A 
Day Low $9.85    EPS $-0.68 
Volume 1,943,255